-Wall Street Journal Report
Abbott Unveils Late-Breaking Data Showing The World’s First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Safety And Performance Endpoints; To Present On May 19-21 At The Heart Rythm Society Annual Meeting
Abbott's AVEIR™ DR i2i™ IDE study is the industry's first prospective study on the safety and performance of the world's first dual-chamber leadless pacemakerThe study successfully met all three of its
